Orthostatic hypotension
Orthostatic hypotension is a significant drop in blood pressure after a person stands up. MeSH defines it as a fall of 20 mm Hg in the upper (systolic) number or 10 mm Hg in the lower (diastolic) number three minutes after rising from lying down to standing, and says the symptoms generally include dizziness, blurred vision and fainting. A US government lab-test page describes it as a sudden drop in blood pressure that makes you dizzy when you get up from sitting or lying down. A US government patient page on low blood pressure defines low blood pressure as a reading of 90/60 or lower and says it is a problem only if it causes dizziness, fainting or, in extreme cases, shock.
Also called Hypotension, Orthostatic
- Condition
- In this atlas
Overview
Technical summary
MeSH D007024 (exact), last updated 2010-06-25; the thresholds rest on its scope note, which calls orthostatic hypotension a finding. The MedlinePlus low blood pressure summary is about low blood pressure in general; the sentence on standing up too quickly is the one that touches this condition. The lab-test page lists finding the cause of orthostatic hypotension among the uses of an aldosterone test. No causes, treatment guidance, frequency figure or trial result is recorded on this page.
Recognition
MeSH says the symptoms generally include dizziness, blurred vision and fainting. A US government patient page says some people may have symptoms of low blood pressure when standing up too quickly.
Burden
No burden claims are published.
Claims and evidence
No claims are published for this condition yet.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Evaluated for this: Tilt-table test
Applies to Recipient not specified People evaluated for syncope with a tilt-table test (MeSH scope note and a Cureus study introduction)
Population, setting and follow-up
- Patients who have a vasodepressive or cardioinhibitory response as a cause of syncope (MeSH) and patients with unexplained syncope (the Cureus introduction). Only background statements are used, not the study results.
- Not stated for the statements used; the Cureus study was done in a hospital in Kaunas, Lithuania.
- Not stated. The sources read do not name a country.
- Not stated for the statements used; the Cureus study included adults aged 18 or older.
- Gestational age Not reported
- Postnatal age Not reported
MeSH describes the tilt-table test as a standard and widely accepted diagnostic test used to identify patients who have a vasodepressive and/or cardioinhibitory response as a cause of syncope. The introduction of a 2026 Cureus study says tilt-table testing is commonly used in clinical practice to evaluate patients with unexplained syncope and plays a key role in distinguishing between syncope mechanisms such as orthostatic hypotension and vasovagal syncope.Limitations. A vocabulary scope note and background statements from the introduction of one study. Neither gives accuracy figures, a protocol, or who should have the test.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 5
Record details
- Record id
cardio:orthostatic-hypotension- Content hash
f5c9a7cf181801eecbcc5bcc583084d37ab6176237f9e700e1fa2d9d83f20642